BD PharmingenTM FITC Rat Anti-Human CCR7 (CD197)

Description

Flow cytometric analysis of CCR7 CD197 expression on human lymphocytes. Whole blood was stained with either FITC Rat IgG2a, kappa Isotype Control Cat. No. 560548; shaded histogram and middle panel or FITC Rat Anti-Human CCR7 CD197 Cat. No. 560548/561675; unshaded histogram and right panel . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . Histograms and dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed on a BD LSR II flow cytometry system. Flow cytometric analysis of CCR7 CD197 expression on human lymphocytes. Whole blood was stained with either FITC Rat IgG2a, kappa Isotype Control Cat. No. 560548; shaded histogram and middle panel or FITC Rat Anti-Human CCR7 CD197 Cat. No. 560548/561675; unshaded histogram and right panel . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . Histograms and dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed on a BD LSR II flow cytometry system. Flow cytometric analysis of CCR7 CD197 expression on human lymphocytes. Whole blood was stained with either FITC Rat IgG2a, kappa Isotype Control Cat. No. 560548; shaded histogram and middle panel or FITC Rat Anti-Human CCR7 CD197 Cat. No. 560548/561675; unshaded histogram and right panel . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . Histograms and dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed on a BD LSR II flow cytometry system. Show More Flow cytometric analysis of CCR7 CD197 expression on human lymphocytes. Whole blood was stained with either FITC Rat IgG2a, kappa Isotype Control Cat. No. 560548; shaded histogram and middle panel or FITC Rat Anti-Human CCR7 CD197 Cat. No. 560548/561675; unshaded histogram and right panel . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . Histograms and dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed on a BD LSR II flow cytometry system. Show More Flow cytometric analysis of CCR7 CD197 expression on human lymphocytes. Whole blood was stained with either FITC Rat IgG2a, kappa Isotype Control Cat. No. 560548; shaded histogram and middle panel or FITC Rat Anti-Human CCR7 CD197 Cat. No. 560548/561675; unshaded histogram and right panel . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . Histograms and dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed on a BD LSR II flow cytometry system. Flow cytometric analysis of CCR7 CD197 expression on human lymphocytes. Whole blood was stained with either FITC Rat IgG2a, kappa Isotype Control Cat. No. 560548; shaded histogram and middle panel or FITC Rat Anti-Human CCR7 CD197 Cat. No. 560548/561675; unshaded histogram and right panel . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . Histograms and dot plots were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed on a BD LSR II flow cytometry system.